Gilead and Galapagos Announce Tortuga Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring
